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Background
Of the three opioid receptors, μ (MOP), δ (DOP) and 
(KOP), the MOP type is the most involved in the action
of opioids in the gut. Experimental studies on models of
intestinal inflammation and inflammatory bowel disease
(IBD) support an anti-inflammatory role of peripheral
MOP receptors in the gut, besides their involvement in
pain control (analgesia) and gastrointestinal motility
(anti-diarrheal effects). Research focuses increasingly on
exploring the therapeutic potential of peripheral MOP
receptors aiming for identification of peripheral ligands
as improved treatment for debilitating conditions asso-
ciated with bowel functions. One strategy to increase
peripheral selectivity includes chemical modifications
that enhance hydrophilicity [1,2]. Our work in the field of
peripherally acting opioids has led to a series of opioids
with zwitterionic moieties (i.e. amino acid residues)
attached to the C-6 position of 14-O-methyloxymor-
phone, which may represent novel therapeutic molecules
for IBD. These 14-alkoxymorphinans were pharmacologi-
cally and immunologically characterized.
Methods
Synthesis of novel zwitterionic 14-alkoxymorphinans
was accomplished by multi-step syntheses. Binding,
functional and immunomodulatory activities were deter-
mined in vitro. Antinociceptive activities were assessed
using acetic acid-induced writhing and tail-flick tests.
Physicochemical properties (logP and logD) were deter-
mined using the MarvinSketch software.
Results
In vitro, the new 6-amino-acid-substituted 14-alkoxymor-
phinans bound with high affinity and showed agonist
activity towards the MOP receptor. They significantly
inhibited the nuclear transcription factor kappaB (NF-
B) activation in tumor-necrosis factor-a (TNF-a) and
lipopolysaccharide (LPS)-stimulated human monocytic
THP-1 cells. In vivo, they produced dose-dependent anti-
nociceptive effects in mice after subcutaneous adminis-
tration, being several-fold more potent than morphine.
Based on the calculated logP and logD values, an increase
of hydrophilicity, and thus peripheral selectivity can be
achieved by attachment of amino acid residues to the
morphinan skeleton.
Conclusions
Novel MOP agonists acting in the periphery with com-
bined immunosuppressive and analgesic properties may
provide a new approach for the treatment of IBD.
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